Using Your Smartphone to Transform Chronic Disease Management, Health News, ET HealthWorld

Using Your Smartphone to Transform Chronic Disease Management, Health News, ET HealthWorld

By Dr. Suhas Patel

chronic diseases Like high blood pressure, diabetes are also called lifestyle diseases. So, it seems that treating these diseases is as simple as improving your lifestyle by changing your behavior, right? But as we can all agree, knowing is not the same as doing. When it comes to exercising and eating right, you know you have to do it, but how hard is it to make sure you do it consistently? Behavior change is complicated. It needs consistency and constant push to make it an actionable reality.

Your pocket probably holds the next blockbuster treat

digital therapies (DTx) is an innovative concept that offers powerful and compelling capabilities in healthcare. Its use through a tool as simple as a smartphone enables precision in treatment and personalization of treatment. As we move to value-based care, DTx plays an important role in it. DTx refers to the application of digital technology to facilitate the prevention, treatment and management of disease. Using smartphones, wearable devices and health monitors, patients can report their health standards and get advice from a team of healthcare professionals for treatment adherence and behavior change. When combined with conventional medicine treatment, DTx can help patients manage chronic diseases independently. All this at your fingertips, on your smartphone.

Research studies indicate improved patient outcomes

A recent study by demountable Chronic Disease management (CDM), based in Bangalore, has demonstrated the effectiveness of digital therapies in managing hypertension (high blood pressure). An intervention program, where participants adopted Phable for 12 weeks, was designed for the daily management of their health. DTx interventions included modification of diet, physical activity, patient education, self-monitoring, and stress management.

At the end of 12 weeks, the participants had reduced their blood pressure by an average of 28/19 mmHg from a baseline reading of 155/127 mmHg to 127/82 mmHg. Among the participants, 67.6% returned to controlled blood pressure levels of <140/90 mmHg while 35.2% of the participants achieved an optimal blood pressure reading of <130/80 mmHg. Notably, as the severity of the hypertension increased, the participants saw a greater benefit in terms of blood pressure reduction.

Wide general adaptation of Phable’s DTx application, when combined with primary care, can be effective in reducing hypertension in patients with uncontrolled hypertension. If DTx is continued for a longer period, medications, frequent visits to the hospital, and corresponding expenses can be avoided.

DTx advantage

There are many advantages to digital therapies, the biggest being the lack of side effects, unlike medication. Its benefits also extend to preventing and easily managing other health problems related to the initial condition, such as diabetes, hyperlipidemia, and cardiovascular disease. On an individual level, DTx can help you manage your health from the comfort of your own home, just with a device we use throughout the day. Incredibly, managing chronic diseases is no more difficult than using a social app.

In India, DTx has enormous utility and scope, given that the healthcare infrastructure is still developing, leaning more towards urban centres, and not within the reach of a large segment of the population. With 1 billion smartphone users in India by 2026, with effective use of DTx, we are poised to make healthcare accessible, affordable and effective for all.

Dr. Suhas Patil, Director, Clinical Strategy, Phable

(Disclaimer: The opinions expressed are those of the author only and are not necessarily shared by ETHealthworld. ETHealthworld.com is not responsible for any harm caused directly or indirectly to any person/organization.)


#Smartphone #Transform #Chronic #Disease #Management #Health #News #HealthWorld

Leave a Comment

Your email address will not be published. Required fields are marked *